MTOR and cancer: Pan-cancer analysis of the SLC25 family suggests that SLC25A4 is linked to multiple oncogenic pathways, including the PI3K-AKT-MTOR pathway, MYC-TARGETS-V1 pathway, MYC-TARGETS-V2 pathway, and MTORC1 pathway (38).